PMC:3342329 / 0-169 JSONTXT 19 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T820 0-10 NN denotes Deficiency
T821 11-13 IN denotes of
T822 14-17 NNP denotes C-C
T823 18-27 NNP denotes Chemokine
T824 28-36 NNP denotes Receptor
T825 37-38 CD denotes 5
T826 39-49 NNPS denotes Suppresses
T827 50-55 NNP denotes Tumor
T828 56-84 NNP denotes Development via Inactivation
T829 85-87 IN denotes of
T830 88-90 NNP denotes NF
T831 90-91 : denotes -
T832 91-92 . denotes κ
T833 92-93 NNP denotes B
T834 94-97 CC denotes and
T835 98-110 NNP denotes Upregulation
T836 111-113 IN denotes of
T837 114-120 NNP denotes IL-1Ra
T838 121-123 IN denotes in
T839 124-132 NNP denotes Melanoma
T840 133-138 NNP denotes Model
R425 T820 T820 ROOT Deficiency,Deficiency
R426 T821 T820 prep of,Deficiency
R427 T822 T824 compound C-C,Receptor
R428 T823 T824 compound Chemokine,Receptor
R429 T824 T821 pobj Receptor,of
R430 T825 T826 nummod 5,Suppresses
R431 T826 T828 compound Suppresses,Development via Inactivation
R432 T827 T828 compound Tumor,Development via Inactivation
R433 T828 T820 conj Development via Inactivation,Deficiency
R434 T829 T828 prep of,Development via Inactivation
R435 T830 T829 pobj NF,of
R436 T831 T828 punct -,Development via Inactivation
R437 T832 T828 punct κ,Development via Inactivation
R439 T834 T833 cc and,B
R440 T835 T833 conj Upregulation,B
R441 T836 T835 prep of,Upregulation
R442 T837 T836 pobj IL-1Ra,of
R443 T838 T833 prep in,B
R444 T839 T838 pobj Melanoma,in